Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults aged 18 or older at the time of signing the consent form
- People with non-small cell lung cancer confirmed by tissue testing, where the cancer cannot be surgically removed, and where testing has confirmed that the EGFR and ALK gene mutations are not present
- People who have at least one measurable tumour, measuring 10mm or more in its longest dimension, visible on a CT or MRI scan
- People whose physical functioning was assessed as good (scoring 0 or 1 on a standard performance scale) within 3 days before starting treatment
- People with a life expectancy of at least 3 months
- People whose major organs (such as heart, lungs, liver, and kidneys) are functioning adequately
- People who are willing to participate, have signed the consent form, and are able to cooperate with follow-up visits
Who may not be able to join:
- People who have serious breathing-related conditions such as pulmonary fibrosis or active tuberculosis
- People with mental health disorders, blood system diseases, autoimmune diseases, or serious existing conditions affecting the heart, brain, liver, or kidneys
- People who experienced a significant bleeding event requiring a blood transfusion, a medical procedure, or hospitalisation in the 3 months before the first dose — or who currently have bleeding symptoms or factors that may raise the risk of bleeding, such as a tumour near major blood vessels, significant tumour tissue breakdown, or enlarged veins in the oesophagus
- People with blood clotting disorders, a history of blood clots or blockages in blood vessels, or a tendency to bleed
- People with a known or suspected allergy to the study drug or any of its ingredients
- Women who are pregnant, breastfeeding, or who are of childbearing potential and have returned a positive pregnancy test at the start of the study
- People who, in the opinion of the research team, have other circumstances that may make completing the study unsafe or unsuitable (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Gang Jin, Dr., Second Hospital of Shanxi Medical University
Phone: +86 351 3365422
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
security; Incidence rate of radiation pneumonia
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.